Role of host factors in SARS-CoV-2 entry
- PMID: 34058196
- PMCID: PMC8160279
- DOI: 10.1016/j.jbc.2021.100847
Role of host factors in SARS-CoV-2 entry
Abstract
The zoonotic transmission of highly pathogenic coronaviruses into the human population is a pressing concern highlighted by the ongoing SARS-CoV-2 pandemic. Recent work has helped to illuminate much about the mechanisms of SARS-CoV-2 entry into the cell, which determines host- and tissue-specific tropism, pathogenicity, and zoonotic transmission. Here we discuss current findings on the factors governing SARS-CoV-2 entry. We first reviewed key features of the viral spike protein (S) mediating fusion of the viral envelope and host cell membrane through binding to the SARS-CoV-2 receptor, angiotensin-converting enzyme 2. We then examined the roles of host proteases including transmembrane protease serine 2 and cathepsins in processing S for virus entry and the impact of this processing on endosomal and plasma membrane virus entry routes. We further discussed recent work on several host cofactors that enhance SARS-CoV-2 entry including Neuropilin-1, CD147, phosphatidylserine receptors, heparan sulfate proteoglycans, sialic acids, and C-type lectins. Finally, we discussed two key host restriction factors, i.e., interferon-induced transmembrane proteins and lymphocyte antigen 6 complex locus E, which can disrupt SARS-CoV-2 entry. The features of SARS-CoV-2 are presented in the context of other human coronaviruses, highlighting unique aspects. In addition, we identify the gaps in understanding of SARS-CoV-2 entry that will need to be addressed by future studies.
Keywords: ACE2; RNA virus; SARS-CoV-2; TMPRSS2; cathepsin B; endocytosis; entry cofactor; membrane fusion; virus entry; virus receptor.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest with the contents of this article.
Figures


Similar articles
-
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.Cells. 2021 Jun 8;10(6):1434. doi: 10.3390/cells10061434. Cells. 2021. PMID: 34201214 Free PMC article.
-
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1. Cell Mol Biol Lett. 2022. PMID: 35109786 Free PMC article. Review.
-
Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.Rev Med Virol. 2021 Sep;31(5):1-9. doi: 10.1002/rmv.2207. Epub 2020 Dec 26. Rev Med Virol. 2021. PMID: 33368788 Free PMC article. Review.
-
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).Int J Mol Med. 2022 Feb;49(2):20. doi: 10.3892/ijmm.2021.5075. Epub 2021 Dec 22. Int J Mol Med. 2022. PMID: 34935057 Free PMC article. Review.
-
Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.J Med Virol. 2021 Sep;93(9):5260-5276. doi: 10.1002/jmv.27019. Epub 2021 May 3. J Med Virol. 2021. PMID: 33851732 Free PMC article. Review.
Cited by
-
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al.J Thromb Haemost. 2022 Sep;20(9):2159-2160. doi: 10.1111/jth.15791. J Thromb Haemost. 2022. PMID: 35968794 Free PMC article. No abstract available.
-
Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.Viruses. 2021 Dec 24;14(1):35. doi: 10.3390/v14010035. Viruses. 2021. PMID: 35062238 Free PMC article. Review.
-
Infectious and Immunological Links Between Periodontitis and COVID-19: A Review.Med Sci Monit. 2025 May 26;31:e948069. doi: 10.12659/MSM.948069. Med Sci Monit. 2025. PMID: 40418682 Free PMC article. Review.
-
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19.Future Virol. 2023 Jun;18(9):563-574. doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13. Future Virol. 2023. PMID: 38051999 Free PMC article.
-
The emergence of SARS-CoV-2 lineages and associated saliva antibody responses among asymptomatic individuals in a large university community.PLoS Pathog. 2023 Aug 21;19(8):e1011596. doi: 10.1371/journal.ppat.1011596. eCollection 2023 Aug. PLoS Pathog. 2023. PMID: 37603565 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous